Search
                    Autism Paid Clinical Trials in Alabama
A listing of 7  Autism  clinical trials  in Alabama  actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
            1 - 7 of 7
        
        
    
                The state of Alabama currently has 7 active clinical trials seeking participants for Autism research studies. These trials are conducted in various cities, including Birmingham, Mobile, Huntsville and Anniston. 
            
                                Featured Trial
                
                Healthy Participants Needed (Colonoscopy + Cancer Screening)
            
        Recruiting
            
        Earn $325 - $475 in electronic payment card compensation for your time and effort by participating in a clinical study to develop a blood test that may one day help screen for colon cancer. Take a quick quiz to see if you qualify.
    
    
                            Conditions: 
                                    
        
            
                        Healthy
                    
                                    
                        Healthy Volunteers
                    
                                    
                        Healthy Subjects
                    
                                    
                        Healthy Volunteer
                    
                                    
                        Healthy Participants
                    
                                    Featured Offer
                
                Lose Weight with GLP-1 Medications
            
        Recruiting
            
        Policy Lab has partnered with OnlineSemaglutide.org to offer trusted access to semaglutide and other GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®. 
GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $50 off your first program with code policy-lab-50.
    GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $50 off your first program with code policy-lab-50.
                            Conditions: 
                                    
        
            
                        Overweight
                    
                                    
                        Overweight and Obesity
                    
                                    
                        Obesity
                    
                                    
                        Weight Loss
                    
                                    
                        Morbid Obesity
                    
                                    Featured Trial
                
                Stroke Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Stroke
    
    
                            Conditions: 
                                    
        
            
                        Stroke
                    
                                    Featured Trial
                
                Chronic Kidney Disease (CKD) Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Chronic Kidney Disease (CKD)
    
    
                            Conditions: 
                                    
        
            
                        Chronic Kidney Disease (CKD)
                    
                                    Featured Trial
                
                Ischemic heart disease (IHD) Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Ischemic heart disease (IHD)
    
    
                            Conditions: 
                                    
        
            
                        Ischemic heart disease (IHD)
                    
                                    Featured Trial
                
                Cardiovascular Disease Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Cardiovascular Disease
    
    
                            Conditions: 
                                    
        
            
                        Cardiovascular Disease
                    
                                    
                
                                    Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder in Pediatric Patients
                                
            
            
        Recruiting
                            
            
                This is a multicenter, randomized, double-blind, placebo-controlled study in pediatric patients aged 5 to 17 years with a primary diagnosis of irritability associated with Autism Spectrum Disorder (ASD) based on Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition Text Revision (DSM-5-TR) and confirmed by the Kiddie Schedule for Affective Disorders and Schizophrenia Present and Lifetime Version (K-SADS-PL).             
        
        
    Gender:
                ALL
            Ages:
                Between 5 years and 17 years
            Trial Updated:
                07/02/2025
            
            Locations: Clinical Site, Dothan, Alabama         
        
        
            Conditions: Irritability Associated With Autism Spectrum Disorder
        
            
        
    
                
                                    ML-004 in Adolescents and Adults With Autism Spectrum Disorders (ASD)
                                
            
            
        Recruiting
                            
            
                ML-004-002 is a multi-center, randomized, double-blind, parallel-group, placebo-controlled study that will enroll approximately 150 adolescent and adult subjects with ASD. The primary objective is to evaluate the efficacy of ML-004 compared with placebo in the improvement of social communication deficits in subjects with ASD.             
        
        
    Gender:
                ALL
            Ages:
                Between 12 years and 45 years
            Trial Updated:
                06/18/2025
            
            Locations: Harmonex Neuroscience Research, Dothan, Alabama         
        
        
            Conditions: Autism Spectrum Disorder
        
            
        
    
                
                                    Comparing Two Different Emotion Therapies for Autistic Youth and Young Adults
                                
            
            
        Recruiting
                            
            
                Too few clinicians are able and willing to help autistic patients. A recent review identified challenges to mental health service delivery in autism, including a lack of interventions designed for community implementation and limited workforce capacity. It has been argued that improving impairment in emotion regulation has the potential to improve a range of mental health difficulties in autistic people. In this clinical trial, the investigators are comparing two evidence-based interventions for...  Read More             
        
        
    Gender:
                ALL
            Ages:
                Between 10 years and 30 years
            Trial Updated:
                05/27/2025
            
            Locations: University of Alabama, Tuscaloosa, Alabama         
        
        
            Conditions: Autism Spectrum Disorder
        
            
        
    
                
                                    The Impact of a Virtual Magic Trick Training Program
                                
            
            
        Recruiting
                            
            
                The proposed project will attempt to confirm the benefits of a structured magic trick training program (MTTP) experience in adolescents with autism. Benefits of participating in a 6-week virtual MTTP will be evaluated using validated assessments to measure social-emotional competencies.             
        
        
    Gender:
                ALL
            Ages:
                Between 11 years and 18 years
            Trial Updated:
                02/03/2025
            
            Locations: University of Alabama at Birmingham, Birmingham, Alabama         
        
        
            Conditions: Autism, Pervasive Developmental Disorder
        
            
        
    
                
                                    STEPS Implementation Trial
                                
            
            
        Recruiting
                            
            
                This study will inform understanding of how to support emerging adults with autism spectrum disorder (ASD). The investigators will use a theoretically informed and research-based transition support program developed for people with ASD and test how effective it is when delivered by community agencies. Results will provide information on the effectiveness of the program as well as on mechanisms of change and contextual factors that promote or impede implementation.             
        
        
    Gender:
                ALL
            Ages:
                Between 16 years and 25 years
            Trial Updated:
                08/14/2024
            
            Locations: Center o=for Youth Development and Intervention, Tuscaloosa, Alabama         
        
        
            Conditions: Autism Spectrum Disorder
        
            
        
    
                
                                    Efficacy of Reading Intervention on the Brain Connectivity in Autism
                                
            
            
        Recruiting
                            
            
                The overarching goal of this proposal is to test the impact of a comprehensive reading intervention program (Visualizing and Verbalizing) on changing the neurobiological mechanisms underlying reading comprehension deficits in children with autism spectrum disorders (ASD). To this end, the investigators will test a group of children with ASD and NT control participants who share common characteristic of average level decoding along with below average reading comprehension. Inclusion of an additio...  Read More             
        
        
    Gender:
                ALL
            Ages:
                Between 7 years and 13 years
            Trial Updated:
                11/29/2023
            
            Locations: University of Alabama, Tuscaloosa, Alabama         
        
        
            
        
    
                
                                    Improving Outcomes in Autism: Community Implementation of Stepped Transition in Education Program
                                
            
            
        Recruiting
                            
            
                The goal of this study is to conduct the first community-based implementation of the STEPS program and test feasibility and preliminary impact. After first working with stakeholders to refine and optimize the program we will launch a Hybrid Type 1 open trial, targeting 25 transition-age youth (TAY) with ASD.             
        
        
    Gender:
                ALL
            Ages:
                Between 16 years and 25 years
            Trial Updated:
                11/29/2023
            
            Locations: Center for Youth Development and Intervention, Tuscaloosa, Alabama         
        
        
            Conditions: Autism Spectrum Disorder
        
            
        
    1 - 7 of 7
            
            
        